TRPM8 and cancer: Given TRPM8 is overexpressed in oral squamous cell carcinoma (SCC), its antagonist RQ-00203078 was used to prove a reduction in the invasion and migration capability of SCC cancer cells, via a reduction on calcium influx [227].